Back to search
FDAFDA · Food and drugs·Recall number Z-0879-2021

EMBLEM S-ICD Subcutaneous Electrode Model 3501. Component of implantable cardioverter defibrillator (ICD)

Published January 27, 2021 · Recall initiated: November 13, 2020

Summary

FDA records medical device Class I recall Z-0879-2021, published January 27, 2021 and initiated November 13, 2020. Recalling firm: Boston Scientific Corporation; Status: Terminated; Reported quantity: 47000 units; Lot: All serialized EMBLEM Subcutaneous Electrodes Model 3501 manufactured and distributed are subject to this worldwide advisory communication. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is potential for fractures which results in the inability to delivery therapy.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Boston Scientific Corporation
Distributor
Worldwide distribution including US and US territories, Canada, Latin America, Europe, Middle East, Africa, and Asia-Pacific region
Lot
All serialized EMBLEM Subcutaneous Electrodes Model 3501 manufactured and distributed are subject to this worldwide advisory communication.
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was EMBLEM S-ICD Subcutaneous Electrode Model 3501. Component of implantable cardioverter defibrillator (ICD) recalled?

Yes. FDA published recall Z-0879-2021 on January 27, 2021. Reported hazard: There is potential for fractures which results in the inability to delivery therapy.

What should I do if I have this product?

Voluntary: Firm initiated · Letter